Phentermine Dosing and Patient Counseling
Phentermine should be dosed at 15-37.5 mg orally once daily, taken in the morning approximately 2 hours after breakfast, with dosage individualized to achieve adequate response with the lowest effective dose. 1
Dosing Recommendations
- Starting dose: 15 mg daily, titrated based on response and tolerability 2, 1
- Maximum dose: 37.5 mg daily 1
- Alternative dosing options:
- Half tablet (18.75 mg) twice daily
- Low-dose 8 mg tablet up to 3 times per day (brand name Lomaira) 2
- Special populations: Limit dosage to 15 mg daily for patients with severe renal impairment (eGFR 15-29 mL/min/1.73 m²) 1
- Timing: Take in the morning; avoid late evening administration to prevent insomnia 1
- Administration: Can be taken with or without food 1
Patient Counseling Points
Key Information to Provide
Short-term use: Phentermine is FDA-approved only for short-term use (up to 3 months) as an adjunct to diet and lifestyle modification 1
Expected weight loss: Approximately 5-6% of body weight at 28 weeks 2
Common side effects:
Serious risks:
- Primary pulmonary hypertension
- Valvular heart disease
- Increased blood pressure
- Effects on ability to perform hazardous tasks 1
Contraindications:
- Cardiovascular disease
- During or within 14 days of MAOI use
- Hyperthyroidism
- Glaucoma
- Agitated states
- History of drug abuse
- Pregnancy or nursing
- Known hypersensitivity to sympathomimetic amines 2
Drug interactions:
- Serotonergic drugs
- Tramadol
- Alcohol
- May require reduction in dose of insulin or oral hypoglycemic medications in diabetic patients 2
Monitoring Requirements
- Efficacy assessment: At least monthly for the first 3 months
- Blood pressure and heart rate: Every 2 weeks during the first 12 weeks
- Discontinuation criteria: Less than 5% weight loss at 12 weeks, or if new, unexplained symptoms of dyspnea, angina, syncope, or lower extremity edema develop 2
Discontinuation and Tapering
When discontinuing phentermine, gradual tapering is recommended to minimize withdrawal effects:
| Week | Dose |
|---|---|
| 1 | 18.75mg daily (half tablet) |
| 2 | 18.75mg every other day |
| 3 | Discontinue completely |
Important Warnings
- Tolerance development: Patients should be informed about the potential for developing tolerance 1
- Risk of dependence: Keep medication in a safe place to prevent theft, accidental overdose, misuse, or abuse 1
- Cardiovascular risks: Particularly important in older adults who may have heightened sensitivity to sympathomimetic effects 2
- CNS effects: Can cause overstimulation, restlessness, dizziness, insomnia, euphoria, dysphoria, tremor, headache, and even psychosis 2
Clinical Pearls
- The combination of phentermine with other weight loss medications is not recommended unless specifically approved (e.g., phentermine-topiramate ER) 1
- Weight loss is greatest in the first weeks of therapy and tends to decrease in succeeding weeks 1
- Recent observational studies have not identified an increased risk of cardiovascular events with phentermine use, though rigorous long-term safety data is limited 4
- For patients who don't respond adequately after 3 months, some evidence suggests that continuing to 6 months may be beneficial, with approximately 40% of 3-month non-responders achieving at least 5% weight loss by 6 months 5